Optical coherence tomography angiography characteristics of exudative and non-exudative treatment-naïve pachychoroid neovasculopathy [PDF]
International Journal of Ophthalmology, 2023 AIM: To describe the optical coherence tomography angiography (OCTA) characteristics of exudative and non-exudative treatment-naïve pachychoroid neovasculopathy (PNV).
Binshan Lin
exaly +3 more sources
One-Year Outcome of Combination Therapy with Full or Reduced Photodynamic Therapy and One Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy [PDF]
Pharmaceuticals, 2022 This paper evaluates a one-year treatment outcome after full or reduced photodynamic therapy (PDT) and anti-vascular endothelial growth factor (VEGF) combination therapy for pachychoroid neovasculopathy (PNV).
Miki Sato-Akushichi +2 more
exaly +4 more sources
Association of IL-4 with pachychoroid neovasculopathy [PDF]
Scientific Reports, 2023 The purpose of this study was to identify the inflammatory cytokines that were associated with pachychoroid neovasculopathy (PNV). Seventy-five eyes of 75 patients with PNV, 145 eyes of 145 patients with neovascular age-related macular degeneration ...
Takashi Baba +10 more
doaj +2 more sources
Progression of Subclinical Pachychoroid Neovasculopathy to an Active Neovascularization in the Presence of Acquired Vitelliform Lesions. [PDF]
Case Rep Ophthalmol Med, 2021 We describe a unique case of bilateral acquired vitelliform lesions in a 67‐year‐old‐female with pachychoroid associated with subretinal fluid in the right eye (OD) and a nonexudative choroidal neovascular membrane (CNVM) in the left eye (OS). Multimodal imaging performed at baseline and over the ensuing two years showed an increase in the OS ...
Soman M +4 more
europepmc +2 more sources
Pachychoroid neovasculopathy can mimic wet type age-related macular degeneration [PDF]
International Journal of Retina and Vitreous, 2022 Purpose to determine the percentage of patients with pachychoroid neovasculopathy (PNV) among patients who have been misdiagnosed and treated with wet age-related macular degeneration (AMD).
Mohsen Farvardin +5 more
doaj +2 more sources
Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration [PDF]
Clinical Ophthalmology, 2021 Sufian Elfandi,1 Sotaro Ooto,1 Manabu Miyata,1 Naoko Ueda-Arakawa,1 Yousif Subhi,1,2 Kenji Yamashiro,1 Hiroshi Tamura,1 Akio Oishi,1 Masayuki Hata,1 Nagahisa Yoshimura,1 Akitaka Tsujikawa1 1Department of Ophthalmology and Visual Sciences, Kyoto ...
Elfandi S +10 more
doaj +2 more sources
The implications of subretinal fluid in pachychoroid neovasculopathy [PDF]
Scientific Reports, 2021 This study aimed to identify the clinical characteristics and longitudinal changes in exudative pachychoroid neovasculopathy (PNV) and non-exudative PNV.
Geun Woo Lee +5 more
doaj +2 more sources
A Case of Best Disease Accompanied by Pachychoroid Neovasculopathy [PDF]
Türk Oftalmoloji Dergisi, 2019 The aim of this case presentation is to describe ocular findings of a 22-year-old patient with Best vitelliform macular dystrophy accompanied by pachychoroid neovasculopathy.
Figen Batıoğlu +4 more
doaj +2 more sources
Chronic choriocapillaris ischemia in dilated vortex vein region in pachychoroid neovasculopathy [PDF]
Scientific Reports, 2021 We evaluated choroidal congestion using multimodal imaging in pachychoroid neovasculopathy (PNV). In a retrospective case series of 100 eyes of 99 treatment-naïve PNV patients, their clinical records were reviewed and the corresponding multimodal imaging
Hidetaka Matsumoto +5 more
doaj +2 more sources
Efficacy of Intravitreal Brolucizumab Switch in Pachychoroid Neovasculopathy [PDF]
Ophthalmology and TherapyIntroduction This study aimed to evaluate the anatomical and functional outcomes of switching to intravitreally administered brolucizumab (Beovu®, Novartis) in patients affected by pachychoroid neovasculopathy (PNV) who were considered as non-responders ...
Nicolò Ribarich +5 more
doaj +2 more sources